Trial Profile
Treatment of the Dumping Syndrome With Lanreotide Autogel®
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Lanreotide (Primary)
- Indications Dumping syndrome
- Focus Therapeutic Use
- 02 Feb 2017 New trial record